USFDA Inspection of Bio-Analytical Laboratory, Unit 7, Shilpa Medicare Limited, Nacharam, Hyderabad, Telangana

The Bio Analytical Laboratory, Shilpa Medicare Limited, Unit 7, Nacharam, Hyderabad, India was inspected by USFDA from 26 Feb, 2024 to 01 March, 2024.

This unannounced USFDA Inspection has been closed without any 483 observation, stating the satisfactory compliance towards facility, systems and acceptability of data generated from this laboratory.

This newly set up Centre for bio-analytical testing has already received European Regulatory Authority clearance recently and this is the first USFDA inspection.

This Unit of Shilpa Medicare is engaged in testing of biological samples that supports all exploratory pharmacokinetic studies, bioavailability studies and bioequivalence studies, while complying with good clinical practices and good laboratory practices as per the global regulatory standards.

Shares of Shilpa Medicare Limited was last trading in BSE at Rs. 417.10 as compared to the previous close of Rs. 410.85. The total number of shares traded during the day was 46750 in over 1495 trades.

The stock hit an intraday high of Rs. 419.45 and intraday low of 405.20. The net turnover during the day was Rs. 19270166.00.

Source : Equity Bulls

Keywords

ShilpaMedicare INE790G01031 USFDA Inspection